How does sharewise work?
Discuss
Discuss and share predictions for your favorite stocks in the forum. Let your opinion be heard
Show moreTop Buy/Sell (This Month)
| Security | Price | Target price |
|---|---|---|
| Microsoft Corp. | €456.05 | €475.64 |
| Alphabet Inc. A | €168.20 | €189.60 |
| Amazon.com Inc. | €184.76 | €222.93 |
| Security | Price | Target price |
|---|---|---|
| Tesla Inc | €266.65 | €298.33 |
| Rheinmetall AG | €1,769.0 | €1,700.0 |
| T.Rowe Price Group Inc. | €91.29 | €81.50 |
New Top predictions since last week
| Prediction | User | Perf. (%) |
|---|---|---|
| B Replimune Group Inc | Bankster | 34.90% |
| B Solarmax Technology Inc. | Warner | 27.01% |
| B Alnylam Pharmace. | Raymond James | 22.75% |
| Prediction | User | Perf. (%) |
|---|---|---|
| S Solarmax Technology Inc. | Bankster | -33.81% |
| S Figma Inc. | daimler1 | -31.94% |
| S Newegg Commerce Inc. | bundfuture | -23.89% |
Many tell you which stocks to buy.
We measure how often they are right!
Portfolios of our members
This new day by Dom Ruinart
When it comes to stocks, what is important for you?
Find stocks based on your criteria with our sharewise stock finder. All results are based on thousands of votes by our community
Pros and Cons of these stocks (New Predictions)
Syndax Pharmaceuticals Inc
WKN: A2AFL6 / Name: Syndax / Stock / Pharmaceuticals / Small Cap /
Pros
Cons
Replimune Group Inc
WKN: A2JQN1 / Symbol: REPL / Name: Replimune Group / Stock / Small Cap /
Pros
Cons
Try sharewise+ and get hundreds more matching stocks
Sign up for free!Tops & Flops S&P 500
| Security | Price | Change(%) (%) |
|---|---|---|
| Leidos Holdings Inc. | €149.45 | 6.600% |
| Archer-Daniels-Midland Co. | €49.80 | 5.660% |
| Broadridge Financial Sol. | €230.00 | 5.560% |
| Discovery Communications C | €22.42 | 5.110% |
| Pfizer Inc. | €21.38 | 4.940% |
| Security | Price | Change(%) (%) |
|---|---|---|
| Gartner Inc. | €210.80 | -27.540% |
| Vertex Pharmaceuticals Inc. | €324.00 | -20.490% |
| Transdigm Group | €1,224.0 | -13.760% |
| Zebra Technologies A | €261.90 | -11.540% |
| Fidelity National Information Services Inc. | €62.39 | -9.360% |
Courses
Get started on the stock market in these easy steps
Things you will learn:
- What is a stock
- What is a fund
- What is an ETF
- How to open a depot
- How to manage a depot that will regularly beat managed funds
- Why you mostly need patience to succeed on the stock market
Key figures for stocks
Predictions
Top News
Unusual Machines: A Speculation With Tailwinds to Lift Its Price
Unusual Machines (NYSEAMERICAN: UMAC) has an unusual story with its once-China-based manufacturing returning to the U.S. The critical takeaway is that this leading provider of advanced drone
Zebra Technologies: Riding the Automation Wave to Profits
Zebra Technologies' (NASDAQ: ZBRA) stock price advanced following the Q2 earnings release to confirm a market reversal and increase the odds it will set a fresh high soon. The company is
Vertical Aerospace's New Deal and Earnings De-Risk Production
In the first week of August 2025, Vertical Aerospace (NYSE: EVTL) announced a long-term strategic partnership with Aciturri Aerostructures, a major global supplier with deep roots in the
Ride the Rally: 3 Earnings Winners With More Upside Ahead
In the height of earnings season, investors typically watch many of the biggest names across industries for an essential update on how these key businesses—and the broader market—have fared. Only
Applied Digital: Why a Surge in Bullish Bets Signals a New Era
Most investors will tell you that it pays to listen when the market sends a clear signal. On August 1, 2025, the market for Applied Digital Corporation (NASDAQ: APLD) was practically shouting
Supernus (SUPN) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Supernus Pharmaceuticals (SUPN) reported $165.45 million in revenue for the quarter ended June 2025, representing a year-over-year decline of 1.7%. EPS of $0.91 for the same period compares to $0.36
Compared to Estimates, RMR Group (RMR) Q3 Earnings: A Look at Key Metrics
For the quarter ended June 2025, RMR Group (RMR) reported revenue of $154.73 million, down 24.7% over the same period last year. EPS came in at $0.28, compared to $0.37 in the year-ago quarter.
The
ViaSat (VSAT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
For the quarter ended June 2025, ViaSat (VSAT) reported revenue of $1.17 billion, up 4% over the same period last year. EPS came in at $0.17, compared to -$0.26 in the year-ago quarter.
The reported
Service Properties (SVC) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Service Properties (SVC) reported $503.44 million in revenue for the quarter ended June 2025, representing a year-over-year decline of 1.9%. EPS of $0.35 for the same period compares to -$0.45 a
Jackson Financial (JXN) Reports Q2 Earnings: What Key Metrics Have to Say
For the quarter ended June 2025, Jackson Financial (JXN) reported revenue of $1.75 billion, down 37.5% over the same period last year. EPS came in at $4.87, compared to $5.32 in the year-ago
This Week's 5 Top Earnings Charts
Six out of the seven Magnificent 7 stocks have reported second quarter earnings. Only NVIDIA remains. But that doesn’t mean that earnings season is over. This week is another busy earnings week with
News
Ivanhoe Electric (IE) Reports Q2 Loss, Tops Revenue Estimates
Ivanhoe Electric (IE) came out with a quarterly loss of $0.16 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.39 per share a year ago. These figures are adjusted
Carlyle Secured Lending, Inc. (CGBD) Matches Q2 Earnings Estimates
Carlyle Secured Lending, Inc. (CGBD) came out with quarterly earnings of $0.39 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.51 per share a year ago. These
Advanced Energy (AEIS) Reports Q2 Earnings: What Key Metrics Have to Say
Advanced Energy Industries (AEIS) reported $441.5 million in revenue for the quarter ended June 2025, representing a year-over-year increase of 21%. EPS of $1.50 for the same period compares to
Here's What Key Metrics Tell Us About Pacira (PCRX) Q2 Earnings
Pacira (PCRX) reported $181.1 million in revenue for the quarter ended June 2025, representing a year-over-year increase of 1.7%. EPS of $0.74 for the same period compares to $0.89 a year ago.
The
Regal Rexnord (RRX) Reports Q2 Earnings: What Key Metrics Have to Say
Regal Rexnord (RRX) reported $1.5 billion in revenue for the quarter ended June 2025, representing a year-over-year decline of 3.3%. EPS of $2.48 for the same period compares to $2.29 a year ago.
DMC Global (BOOM) Reports Q2 Earnings: What Key Metrics Have to Say
For the quarter ended June 2025, DMC Global (BOOM) reported revenue of $155.49 million, down 9.2% over the same period last year. EPS came in at $0.12, compared to $0.29 in the year-ago quarter.
The
American Well (AMWL) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
For the quarter ended June 2025, American Well Corporation (AMWL) reported revenue of $70.9 million, up 12.9% over the same period last year. EPS came in at -$1.24, compared to -$3.36 in the
ProAssurance (PRA) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
For the quarter ended June 2025, ProAssurance (PRA) reported revenue of $271.94 million, down 2.4% over the same period last year. EPS came in at $0.52, compared to $0.23 in the year-ago quarter.
National CineMedia (NCMI) Reports Q2 Earnings: What Key Metrics Have to Say
National CineMedia (NCMI) reported $51.8 million in revenue for the quarter ended June 2025, representing a year-over-year decline of 5.3%. EPS of -$0.11 for the same period compares to -$0.09 a
Contest
Still running
sharewise
Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer
sharewise+-Mitgliedschaft
unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.
Heibel Ticker
sharewise sagt: Stephan Heibel ist ein langähriger Unterstützer und Autor der Wunschanalyse. Er betreibt meiner Meinung nach einen der besten Börsenbriefe. Es gibt eine kostenlose und eine Premium Variante.
Kostenlos ausprobieren
Leeway
Die Analyse-Plattform Leeway untersucht mit KI-unterstützten Algorithmen aussagekräftige Zusammenhänge am Aktienmarkt. Anhand von vielen Millionen Datenpunkten finden die Algorithmen die Kennzahlen und Bewegungen, die nachweisbare Auswirkungen haben und Vorteile schaffen.
Kostenlos ausprobierensharewise
Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer
sharewise+-Mitgliedschaft
unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.